Evaluation of a topical formulation of eprinomectin against Anopheles arabiensis when administered to Zebu cattle (Bos indicus) under field conditions.
Although vector control strategies, such as insecticide-treated bed nets (ITNs) and indoor residual spraying (IRS) have been effective in Kenya the transmission of malaria continues to afflict western Kenya. This residual transmission is driven in part by Anopheles arabiensis, known for its opportunistic blood feeding behaviour and propensity to feed outdoors. The objective of this research was to evaluate the efficacy of the drug eprinomectin at reducing malaria vector density when applied to cattle (Bos indicus), the primary source of blood for An. arabiensis, under field conditions.



A pilot study was carried out in the Samia District of western Kenya from September to October of 2014. Treatment and control areas were randomly designated and comprised of 50 homes per study area. Before cattle treatments, baseline mosquito counts were performed after pyrethrum spray. Cows in the treatment area were administered topical applications of eprinomectin at 0.5 mg/kg once a week for two consecutive weeks. Mosquito collections were performed once each week for two weeks following the eprinomectin treatments. Mosquitoes were first identified morphologically and with molecular confirmation, then screened for sporozoite presence and host blood using PCR-based methods.



The indoor resting density of An. arabiensis was significantly reduced by 38 % in the treatment area compared to the control area at one-week post-treatment (Control mean females per hut = 1.33 95 % CI [1.08, 1.64]; Treatment = 0.79 [0.56, 1.07]). An increase in the indoor resting density of Anopheles gambiae s.s. and Anopheles funestus s.s. was observed in the treatment area in the absence of An. arabiensis. At two weeks post-treatment, the total number of mosquitoes for any species per hut was not significantly different between the treatment and control areas. No change was observed in An. arabiensis host preference as a result of treatment.



Systemic drugs may be an important tool by which to supplement existing vector control interventions by significantly impacting outdoor malaria transmission driven by An. arabiensis through the treatment of cattle.
Genesis Laboratories, 10122 NE Frontage Rd, Wellington, CO, USA. saul@genesislabs.com.
Saul
S
Lozano-Fuentes
Genesis Laboratories, 10122 NE Frontage Rd, Wellington, CO, USA.|Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA.
Rebekah C
RC
Kading
Genesis Laboratories, 10122 NE Frontage Rd, Wellington, CO, USA.
Daniel A
DA
Hartman
International Livestock Research Institute, P.O. Box 30709, Nairobi, Kenya.
Edward
E
Okoth
International Livestock Research Institute, P.O. Box 30709, Nairobi, Kenya.
Naftaly
N
Githaka
International Livestock Research Institute, P.O. Box 30709, Nairobi, Kenya.
Vishvanath
V
Nene
Genesis Laboratories, 10122 NE Frontage Rd, Wellington, CO, USA.
Richard M
RM
Poché
D000287:Administration, Topical; D000818:Animals; D000852:Anopheles / Q000187:drug effects*; D002417:Cattle; D004478:Ectoparasitic Infestations / Q000517:prevention & control*; D005260:Female; D007306:Insecticides / Q000008:administration & dosage*; D007559:Ivermectin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D007630:Kenya; D008297:Male; D000072138:Mosquito Vectors; D010865:Pilot Projects
D007306:Insecticides; D007559:Ivermectin; C101434:eprinomectin
Anopheles arabiensis; Cattle; Endectocide; Eprinomectin; Kenya; Malaria